Records containing: Irritable Bowel Syndrome (IBS)

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

• CLINICAL_TRIALS study record update · 2018-09-24
  The Effects of Human Milk Oligosaccharides on Faecal Microbiota, Gastrointestinal Symptoms, Mucosal Immunity and Barrier Function in Irritable Bowel Syndrome: a Parellell, Double-blind, Randomised, Placebo-controlled Study
• CLINICAL_TRIALS study record update · 2018-02-22
  Genetic Determinism of Epithelial Barrier Defects Induced by Increase in Proteases Activity in Irritable Bowel Syndrome
• CLINICAL_TRIALS study record update · 2017-12-26
  A Phase 2 PoC in IBS Patients With the CRF1 Receptor Anatgonist, GSK876008
• CLINICAL_TRIALS study record update · 2017-05-16
  A Phase IIa Experimental Medicine Study Assessing Alterations in Regional Cerebral Blood Flow by Functional Magnetic Resonance Imaging (fMRI) in Female IBS Patients and Healthy Controls Following Single Doses of GW876008, a Corticotrophin Releasing Factor 1 Receptor Antagonist (CRF1-RA)
• CLINICAL_TRIALS study record update · 2016-04-15
  A Phase 2, Multi-center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
• Organize your saved records without ads with Plus.
• CLINICAL_TRIALS study record update · 2016-03-09
  Peer Mentorship: An Intervention To Promote Effective Pain Self-Management In Adolescents
• CLINICAL_TRIALS study record update · 2016-02-25
  A Phase 2, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study to Evaluate the Effects of ONO-2952 on Pain Perception Produced by Rectal Distention in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) (RESTORE)
• CLINICAL_TRIALS study record update · 2015-12-02
  Exposure-Based CBT for Children With Functional Gastrointestinal Disorders - Development of a Protocol
• CLINICAL_TRIALS study record update · 2015-04-16
  A 12-Week, Randomized, Double-Blind, Placebo- Controlled Study of PRN BID and Fixed Dosing Regimens of Alosetron in Female Subjects With Severe Diarrhea-Predominant Irritable Bowel Syndrome Who Have Failed Conventional Therapy
• CLINICAL_TRIALS study record update · 2015-04-16
  A Twelve-Week, Randomized, Double Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Efficacy of 0.5 mg QD, 1 mg QD and 1 mg BID of Alosetron in Female Subjects With Severe Diarrhea-predominant IBS Who Have Failed Conventional Therapy
• CLINICAL_TRIALS study record update · 2014-04-28
  Assessment of Tolerability & Effectiveness of Progut in Treatment of Irritable Bowel Syndrome
• CLINICAL_TRIALS study record update · 2013-07-18
  The Diagnostic Predictability of Food Allergy Testing in Individuals With Irritable Bowel Syndrome (IBS): A Comparison Between Various Laboratory Methods and an Elimination Diet. (The FAST Study)
• CLINICAL_TRIALS study record update · 2013-02-06
  Abdominal Symptom Phenotype: Pathways to New Biomarkers
• CLINICAL_TRIALS study record update · 2013-01-24
  An Intervention to Improve Physical Activity in IBS Patients Has Long Term Positive Effects
• CLINICAL_TRIALS study record update · 2009-05-18
  A Randomized, Double-Blind, Placebo-Controlled, Crossover, Phase IIa Study to Evaluate Efficacy and Safety of the Beta-3-Adrenergic Receptor Agonist Solabegron in Subjects With Irritable Bowel Syndrome
• CLINICAL_TRIALS study record update · 2009-05-08
  A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Women With Irritable Bowel Syndrome to Evaluate Feasibility and Reproducibility of Barostat Assessments of Colorectal Sensation During Colorectal Distention and Its Pharmacological Modulation Using Octreotide.
• CLINICAL_TRIALS study record update · 2008-10-16
  An Exploratory Phase I Study in Healthy Volunteers of GI Transit Following Administration of the ß3-Adrenergic Receptor Agonist, Solabegron (Study B3I106248)
• CLINICAL_TRIALS study record update · 2008-04-04
  A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Tolerance and Efficacy of the Probiotic E. Coli Strain M17 on Symptoms and Quality of Life in Individuals With Irritable Bowel Syndrome (IBS)
• CLINICAL_TRIALS study record update · 2008-02-25
  A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Pilot Study to Assess the Effects of AV608 on Central Processing of Visceral Stimuli in Subjects With Irritable Bowel Syndrome